News Announcement

Emcure Pharmaceuticals: Outcome Of Board Meeting Held On August 13 2024

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith the Unaudited Financial Results for the quarter ended June 30 2024 along with the Limited Review Reports on the aforesaid results as issued by the B S R & Co. LLP Chartered Accountants Auditors of the Company enclosed as Annexure A.Press Release outlining key updates on the aforesaid results are enclosed as Annexure B.


दूसरी कैटेगरी